Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

The domestic market showed resilience in 2025, with the Nifty 50 up over 10% year-to-date. Experts anticipate better market ...

U.S.-based Eli Lilly & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are vying to capture a large portion of India’s ...

Explore the 2025 Indian stock market's correction, where large-caps prevailed and valuations reshaped investment strategies ...

India’s IPO market hit record highs in 2025, with healthcare, technology and NBFCs emerging as the top contributors, while mainboard listings dominated fundraising by value.

The Indian fixed income market in 2025 is navigating a complex macroeconomic landscape. While inflation has sharply declined and the Reserve Bank of India (RBI) has shifted to a more accommodative ...

For a company with such a wide international footprint, Oyo-parent Prism's choice of India over U.S. exchanges is symbolic ...

After recent IndiGo disruptions exposed risks of a duopoly-led market, the Centre cleared NOCs for two new airlines, ...

India’s jewellery market in 2025 saw resilient demand with a shift to lighter gold, diamonds, and silver, driven by design, value, and evolving lifestyles.

India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising ...

The exports of Russian spirits to India have nearly quadrupled in the first 10 months of the year compared to the same period ...

India's job market in 2025 demonstrated resilience with 9 crore job applications, marking a 29% increase from the previous ...